The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals

Some of the approved drugs are synthetic versions of the natural hormones, such as trenbolone acetate and zeranol. Just like the natural hormone implants, before FDA approved these drugs, FDA required information and/or toxicological testing in laboratory animals to determine safe levels in the animal products that we eat (edible tissues). Furthermore, FDA required that the manufacturers demonstrate that the amount of hormone left in each edible tissue after treatment is below the appropriate safe level. As described above, a safe level is a level which would be expected to have no harmful effect in humans.

Sometimes tumors on the pituitary or adrenal glands can contribute to a condition known as Cushing syndrome , which is characterized by high levels of cortisol in the blood. Individuals with Cushing syndrome will experience rapid weight gain in the face, abdomen, and chest. Often doctors will notice this because of the individual's slender arms and legs compared to the heavy weight in the core of the body. Cushing syndrome also causes a flushed face, high blood pressure, and changes in the skin. Osteoporosis and mood swings are also a factor considered with Cushing disease.

The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals

the steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals

Media:

the steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicalsthe steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicalsthe steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicalsthe steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicalsthe steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals

http://buy-steroids.org